Prokineticin 1 Protein (Prok1) (His tag)

Produktnummer ABIN7318098

Produktdetails

Target: Prokineticin 1 (Prok1)

Protein-Typ: Recombinant

Spezies: Human

Quelle: Baculovirus infected Insect Cells

Aufreinigungstag / Konjugat: Dieses Prokineticin 1 Protein ist gelabelt mit His tag.

Verwendungszweck: Recombinant Human EG-VEGF/prokineticin-1 Protein (His Tag)

Sequenz: Met 1-Phe105

Produktmerkmale: A DNA sequence encoding the human EG-VEGF (Met 1-Phe105) (P58294) was expressed, with a C-terminal polyhistidine tag.

Reinheit: > 89 % as determined by reducing SDS-PAGE.

Endotoxin-Niveau: < 1.0 EU per μg as determined by the LAL method.

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Please refer to the printed manual for detailed information.

Buffer: Lyophilized from sterile 20 mM Tris, 500 mM NaCl, pH 7.4, 0.02 % Tween-80, 10 % glycerol, 1 mM DTT 1. Normally 5 % - 8 % trehalose, mannitol and 0.01 % Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. 2. Please contact us for any concerns or special requirements.

Lagerung: 4 °C,-20 °C,-80 °C

Informationen zur Lagerung: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.

Antigendetails

Target: Prokineticin 1 (Prok1)

Andere Bezeichnung: EG-VEGF/prokineticin-1 (Prok1 Produkte)

Synonyme: PK1 Protein, zgc:171925 Protein, EGVEGF Protein, PRK1 Protein, EG-VEGF Protein, prokineticin 1 Protein, PROK1 Protein, prok1 Protein, Prok1 Protein

Hintergrund:

Background: EG-VEGF, also known as prokineticin-1, is a member of the AVIT (prokineticin) family. Prokineticins are secreted proteins that can promote angiogenesis and induce strong gastrointestinal smooth muscle contraction. EG-VEGF can be detected in the steroidogenic glands, ovary, testis, adrenal and placenta. EG-VEGF has little or no effect on a variety of other endothelial and non-endothelial cell types. It induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It directly influences neuroblastoma progression by promoting the proliferation and migration of neuroblastoma cells. EG-VEGF may play a role in placentation. It may also function in normal and pathological testis angiogenesis. It positively regulates PTGS2 expression and prostaglandin synthesis.

Synonym: EGVEGF,PK1,PRK1

Molekulargewicht: 11 kDa

UniProt: P58294